 PROSPECTIVE AND RETROSPECTIVE COHORT STUDY TO FIND NEW PROGNOSTIC FACTORS AND THERAPEUTIC TARGETS IN PATIENTS WITH NEWLY DIAGNOSED OR RELAPSED MALIGNANT HEMATOLOGIC DISORDER EXCLUDING ACUTE LEUKEMIA: 